Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT07834398
What this trial is testing

Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes

Who this might be right for
Non-diabetec ObesityObesity (Disorder)
Zagazig University 150
Not applicableStudy completedNCT05136287
What this trial is testing

SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.

Who this might be right for
Weight LossDiabetes Mellitus, Type 2Quality of Life+1 more
Jose Seijas Amigo 140
Large-scale testing (Phase 3)Study completedNCT02735031
What this trial is testing

Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Hypoglycemia
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07523633
What this trial is testing

Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder

Who this might be right for
Cannabis Use DisorderCannabis Use DisordersCannabis Abuse+2 more
Anders Fink-Jensen, MD, DMSci 100
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07319286
What this trial is testing

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

Who this might be right for
Menstrual IrregularitiesType1 Diabetes MellitusGlucagon-Like Peptide-1 Receptor Agonists+1 more
Ain Shams University 50
Not applicableNot Yet RecruitingNCT07444073
What this trial is testing

Assessing Biological Aging in a Real-World Medical Weight Loss Program Using the LinAge2 Clinical Clock

Who this might be right for
AgingObesity & Overweight
National University of Singapore 440
Large-scale testing (Phase 3)Looking for participantsNCT07083154
What this trial is testing

Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)

Who this might be right for
Dementia, MildMild Cognitive ImpairmentType 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 420
Post-approval studies (Phase 4)Active Not RecruitingNCT06908694
What this trial is testing

Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
Hamilton Health Sciences Corporation 20
Large-scale testing (Phase 3)Study completedNCT00713830
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 859
Not applicableNot Yet RecruitingNCT06775093
What this trial is testing

Effects of GLP-1RAs on Reproductive Outcomes in PCOS and Obesity

Who this might be right for
Polycystic Ovary SyndromeObesityInfertility, Female
Peking University Third Hospital 392
Testing effectiveness (Phase 2)Looking for participantsNCT07101939
What this trial is testing

The Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)

Who this might be right for
ObesityMuscle Loss
Actimed Therapeutics Ltd 120
Not applicableLooking for participantsNCT06734312
What this trial is testing

MAINTAIN (Mucosal AblatIoN Therapy After INcretins)

Who this might be right for
Obesity and Obesity-related Medical ConditionsObesity and OverweightObesity Prevention+3 more
Dr. Christopher McGowan 20
Not applicableLooking for participantsNCT07736963
What this trial is testing

Discontinuation Recommendations for GLP-1 Receptor Agonists Prior to Colonoscopy

Who this might be right for
GLP-1
Fu Jen Catholic University Hospital 240
Post-approval studies (Phase 4)Study completedNCT03466021
What this trial is testing

Effects of Liraglutide in Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Claus Bogh Juhl 40
Testing effectiveness (Phase 2)Study completedNCT02617654
What this trial is testing

Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Per-Ola Carlsson 18
Not applicableStudy completedNCT06401746
What this trial is testing

Body Surface Gastric Mapping in Patients on Semaglutide

Who this might be right for
Semaglutide-Induced Gastric MotilityGastroparesis
University of Western Sydney 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613437
What this trial is testing

GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial

Who this might be right for
Intracerebral Hemorrhage
Chinese University of Hong Kong 200
Post-approval studies (Phase 4)Ended earlyNCT01381926
What this trial is testing

Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist

Who this might be right for
Type 2 Diabetes MellitusBone Remodeling
University of Alabama at Birmingham 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07511543
What this trial is testing

Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy

Who this might be right for
Ischemic Stroke
Population Health Research Institute 100
Not applicableStudy completedNCT07194317
What this trial is testing

A Feasibility Study to Determine the Most Appropriate Digital Dietary Assessment Tool in Patients With Obesity Initiating GLP-1 Receptor Agonist Treatment

Who this might be right for
Obese Patients
King's College London 64
Next Page